Effect of Cognitive Stimulating Interventions on Cognitive Self-Efficacy and Sense of Happiness Among Older Adults

March 25, 2023 updated by: Alexandria University

Cognitive Stimulating Interventions Improve Cognitive Self- Efficacy and Sense of Happiness Among Older Adults

The present study aims to determine the effect of cognitive stimulation interventions on cognitive self-efficacy and sense of happiness among older adults.

Research hypothesis:

Older adults who receive the cognitive stimulation interventions exhibit higher cognitive self-efficacy and sense of happiness than those who do not receive it.

Study Overview

Status

Completed

Conditions

Detailed Description

A convenient sample of eighty (80) older adults will be used according Epi info V 7.0 program calculation based on the following statistical parameters ; Population size: 250, expected frequency: 50%, confidence coefficient: 95%, acceptable error: 10%, minimum sample size = 70.

The study will include eighty (80) older adults aged 60 years and more and fulfilling the following criteria:

Inclusion criteria

  1. Aged 60 years and old.
  2. Able to read and write.
  3. Have mild cognitive impairment: score of score of 18-23 based on the Mini Mental State Examination Scale (MMSE).
  4. Have no depression: score of 0 to 4 using the Geriatric Depression Scale Short Form (GDS_SF).
  5. Accept participation in the study. 6. Available at the selected setting during the time of data collection. 7. Have no pronounced impairment of their visual and auditory abilities could affect their participation in the group and make use of most of the materials in the sessions, as determined by the researchers.

The selected study subjects (80) will be randomly assigned to two equal groups of 40 older adults each as flows; Group 1, study group: include older adults who will receive the proposed interventions, cognitive stimulation interventions.

Group 2, control group: include older adults who will receive the routine activities of the elderly club.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt, 21523
        • Faculty of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:1. Aged 60 years and old. 2. Able to read and write. 3. Have mild cognitive impairment: score of score of 18-23 based on the Mini Mental State Examination Scale (MMSE).

4. Have no depression: score of 0 to 4 using the Geriatric Depression Scale Short Form (GDS_SF).

5. Accept participation in the study. 6. Available at the selected setting during the time of data collection.

Exclusion Criteria:

  • 7. Have pronounced impairment of their visual and auditory abilities could affect their participation in the group and make use of most of the materials in the sessions, as determined by the researchers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive Stimulating Interventions
The study interventions will be developed by the researchers based on review of the related literature and with reference to the CST manual (Spector, et al., 2006), and review on Cognitive Stimulation (Woods et al., 2012). The study subjects of group 1, the study group, will receive the proposed interventions, the cognitive stimulation interventions through small groups of study subjects receiving 12 sessions of group activities (2 sessions/week, approximately 45- 60 minutes/session). A group size of 6 to 8 will be conducted. The interventions group will be conducted in activity rooms within the elderl club. The study subjects group 2, the control group, will receive the routine activities of the elderly club. The researchers will provide the control group with written materials related the essential cognitive stimulation interventions after ending the implementation of the proposed interventions for the study group.
a quasi-experimental research design.The study subjects of group 1, the study group, will receive the proposed interventions, the cognitive stimulation interventions through small groups of study subjects receiving 12 sessions of group activities (2 sessions/week, approximately 45- 60 minutes/session). A group size of 6 to 8 will be conducted. The interventions group will be conducted in activity rooms within the elderly club.
Active Comparator: Routine Club care
The study subjects group 2, the control group, will receive the routine activities of the elderly club.The researchers will provide the control group with written materials related the essential cognitive stimulation interventions after ending the implementation of the proposed interventions for the study group,
a quasi-experimental research design.The study subjects of group 1, the study group, will receive the proposed interventions, the cognitive stimulation interventions through small groups of study subjects receiving 12 sessions of group activities (2 sessions/week, approximately 45- 60 minutes/session). A group size of 6 to 8 will be conducted. The interventions group will be conducted in activity rooms within the elderly club.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
I) Mini-Mental State Examination (MMS) Scale
Time Frame: 2 weeks

The MMS scale was developed by Folestein et al., (1975). It used to assess cognitive function of the older adults. It contained questions concerning registration, orientation, calculation, recall, attention, and language. The MMS scale score was 30 point and classified as follows: -30. -23. -17.

The MMS was translated into Arabic and approved to be valid and reliable (r=0.96) by El Husseini (2008). The Arabic version of this scale was used in the present study.

2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
II) Geriatric Depression Scale- Short Form (GDS-SF)
Time Frame: 2 weeks

The Geriatric Depression Scale - short Form (GDS-SF), a self-report tool with 15-item developed by Yesavage et al. (1983) to assess general well-being and depression in the elderly. The older adults should select one answer either yes (1) or no (0) for their feelings over the past week. The scores ranged from 0 to 15. Items' score will be calculated for the total score. A score of 0 to 4 meant no depression, score of 5 to 8 meant mild depression, score of 9 to 11 meant moderate depression, and 12-15 meant severe depression.

The GDS-SF was translated into Arabic and approved to be reliable (r=0.70) and valid by ElHusseini (2013). The Arabic version of this scale was used in the current study.

2 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
III) Six -Domains Perceived Cognitive Self-Efficacy for Older Adults Structured Interview Questionnaire
Time Frame: 2 weeks
This tool will be developed by the researchers to assess the cognitive self-efficacy among older adults. It composed of 40 items related to six domains covering six cognitive functions (Everyday Memory, Language, Visuospatial Abilities, Planning, Organization, and Divided attention). Each domain contains several cognitive task related to this domain. Older adults asked to rate how certain they are that they can do each cognitive task. They rate the degree of confidence in their cognitive abitity by recording a number from 0 to 10, next to each statement, where 0 means cannot do at all, 5 moderately certain can do, and 10 indicates highly certain can do.the total score ranges from 0 to 400. The higher the score is the higher cognitive self-efficacy.
2 weeks
IV) The Subjective Happiness Scale (SHS):
Time Frame: 2 weeks
The Subjective Happiness Scale is a 4-item scale that developed by Lyubomirsky, et al., (1999) to measure subjective happiness. Each item is completed by choosing one of 7 options that finish a given sentence fragment. The options are different for each of the four questions. Two items ask respondents to characterize themselves using both absolute ratings and ratings relative to peers, whereas the other two items offer brief descriptions of happy and unhappy individuals and ask respondents the extent to which each characterization describes them. The average of the item scores is an overall measure sense of happiness with high scores indicating greater sense of happiness.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Eman Taha, professor, Egypt Faculty of Nursing Alexandria, Egypt

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2023

Primary Completion (Actual)

February 1, 2023

Study Completion (Actual)

February 10, 2023

Study Registration Dates

First Submitted

March 25, 2023

First Submitted That Met QC Criteria

March 25, 2023

First Posted (Actual)

April 6, 2023

Study Record Updates

Last Update Posted (Actual)

April 6, 2023

Last Update Submitted That Met QC Criteria

March 25, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 15012023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self- Efficacy

Clinical Trials on Cognitive Stimulating Interventions

Subscribe